title: Commentary: Fatal French Clinical Trial: What Can We Learn from What Went Wrong?
authors.affiliation: Department of Pharmaceutical and Pharmacological Sciences University of Padua Padua, Italy. stephen.skaper@unipd.it.
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Skaper
mesh_terms: D017321:Clinical Trials, Phase I as Topic; D003497:Cyclic N-Oxides / Q000009:adverse effects*; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005602:France; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy*; D011725:Pyridines / Q000009:adverse effects*; D017211:Treatment Failure
chemical_list: C000612073:BIA 10-2474; D003497:Cyclic N-Oxides; D004791:Enzyme Inhibitors; D011725:Pyridines